NASDAQ:HGEN Humanigen (HGEN) News Today $0.01 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$0.01▼$0.013050-Day Range$0.01▼$0.2052-Week Range$0.01▼$0.26Volume1.08 million shsAverage Volume2.91 million shsMarket Capitalization$1.54 millionP/E RatioN/ADividend YieldN/APrice Target$0.50 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHumanigen, Inc. (HGEN) stock price, news, quote & history – Yahoo Financeuk.finance.yahoo.com - August 11 at 1:32 AMHumanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantationfinance.yahoo.com - August 7 at 9:48 AMHumanigen stock removed from S&P Total Market Index as firm faces...proactiveinvestors.com - July 30 at 8:10 AMHumanigen stock removed from S&P Total Market Index as firm faces bankruptcyproactiveinvestors.com - July 28 at 9:42 PMHumanigen Shares Plunge 73% as Business Combination Fails, Going Concern Issues Raisedmarketwatch.com - July 25 at 7:28 PMWhy Is Humanigen (HGEN) Stock Down 72% Today?markets.businessinsider.com - July 25 at 9:40 AMHumanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming Largemsn.com - July 25 at 9:40 AMHumanigen to weigh bankruptcy as shares delist from Nasdaqseekingalpha.com - July 25 at 8:24 AMHumanigen (HGEN) Surges on Lenzilumab Study Data for Leukemianasdaq.com - April 17 at 4:50 PMHumanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemiafinance.yahoo.com - April 14 at 1:22 PMHumanigen, Inc. (HGEN) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - December 20 at 1:56 PMHumanigen Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 14 at 7:58 PMHumanigen Announces Participation and Presentation at Jefferies London Healthcare Conferencefinance.yahoo.com - November 10 at 12:22 PMHumanigen Announces Retention of SC&H Capital as Financial Advisorfinance.yahoo.com - October 31 at 8:30 AM2022-10-19 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 19 at 10:14 PMThis Addiction Drug Shows Some Potential Against Long COVID Symptoms - Humanigen (NASDAQ:HGEN), GSK (NYSE - Benzingabenzinga.com - October 19 at 9:59 AMCLASS ACTION UPDATE for HGEN, SQ and OPEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Be - Benzingabenzinga.com - October 19 at 8:16 AMGLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – HGEN - Business Wirebusinesswire.com - October 18 at 10:10 PMROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGENprnewswire.com - October 18 at 4:44 AMBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm - GuruFocus.comgurufocus.com - October 17 at 5:34 PMHGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upc - Benzingabenzinga.com - October 16 at 5:49 PM2022-10-15 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 15 at 5:55 PMHGEN SHAREHOLDER ALERT: Jakubo - GuruFocus.comgurufocus.com - October 14 at 8:44 PM2022-10-14 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 14 at 12:51 PMHGEN LAWSUIT ALERT: Levi & Kor - GuruFocus.comgurufocus.com - October 13 at 9:01 PMROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Bef - Benzingabenzinga.com - October 13 at 9:01 PM2022-10-13 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 13 at 4:09 AMHumanigen Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2022 - Benzingabenzinga.com - October 12 at 5:59 PMBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, - Benzingabenzinga.com - October 11 at 11:04 PM2022-10-09 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 10 at 10:39 PMROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important De - Benzingabenzinga.com - October 10 at 10:39 PMROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN - PR Newswireprnewswire.com - October 8 at 3:09 AMROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGENprnewswire.com - October 8 at 12:48 AMHGEN.N - Humanigen Inc | Stock Price & Latest News | Reutersreuters.com - October 7 at 7:07 AM2022-10-06 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 7 at 1:44 AMBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch F - Benzingabenzinga.com - October 6 at 9:06 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Humanigen, - Benzingabenzinga.com - October 6 at 4:06 PM2022-10-05 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 5 at 11:55 PMCLASS ACTION UPDATE for CPNG, HGEN and SMFR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on - Benzingabenzinga.com - October 4 at 10:47 PMThinking about buying stock in Connect Biopharma, Rivian Automotive, AeroClean Technologies, Kiora Pharmaceuticals, or Humanigen? - PR Newswireprnewswire.com - October 4 at 8:40 AMDBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors - Yahoo Financefinance.yahoo.com - October 3 at 11:58 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Humanigen, Inc. of Class Action Lawsuit and upcoming Deadline - HGEN - PR Newswireprnewswire.com - October 3 at 12:41 PM2022-10-03 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - October 3 at 7:33 AMCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadli - Benzingabenzinga.com - October 3 at 7:33 AMBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm - Coupang (NYSE:CPNG), Humanigen (NASDAQ:HGEN) - Benzingabenzinga.com - October 3 at 12:04 AMCLASS ACTION UPDATE for HGEN, ABT and FLGT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholdersmarketwatch.com - October 2 at 9:00 PMROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Importa - Benzingabenzinga.com - October 1 at 8:57 AM2022-09-30 | NDAQ:HGEN | Press Release | Humanigen Inc. - Stockhousestockhouse.com - September 30 at 7:55 AMHUMANIGEN, INC. (HGEN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Humanigen, Inc. (HGEN) - Humanigen (NASDAQ:HG - Benzingabenzinga.com - September 29 at 11:10 AMCLASS ACTION UPDATE for HGEN, KSS and BCS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholdersbenzinga.com - September 29 at 10:54 AM Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address HGEN Media Mentions By Week HGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HGEN News Sentiment▼1.080.68▲Average Medical News Sentiment HGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HGEN Articles This Week▼10▲HGEN Articles Average Week Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Clearmind Medicine News TransCode Therapeutics News Galmed Pharmaceuticals News China SXT Pharmaceuticals News China Pharma News Evofem Biosciences News Ayala Pharmaceuticals News Histogen News Altamira Therapeutics News Novan News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:HGEN) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humanigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.